Discover 2,388 paid clinical trials in Glenview, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,388
Electrophysiological Representations of Odor Identity Study 2
for
Odor Identity Ratings
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 12 - 65
Code: NCT07386236
Recruiting
Tocilizumab for Acute Chest Syndrome
for
Sickle Cell Disease, Acute Chest Syndrome
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 12+
Code: NCT05640271
Phase 2, Recruiting
Mosaic Trial for Stem Cell Transplant Recipients
for
Hematologic Malignancy, Stem Cell Transplant,
Location: Chicago IL, Washington D.C. DC, Nutley NJ
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06960993
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Location: Chicago IL, Ann Arbor MI, Columbus OH, Kitchener,
Sponsor: UMC Utrecht
Sex: All
Age: 0+
Code: NCT02735707
Phase 3, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Chicago IL, Iowa City IA, St Louis MO, Rochester MN,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Location: Gurnee IL, Burr Ridge IL, Milwaukee WI, Indianapolis IN,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase 3, Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Chicago IL, Zion IL, Milwaukee WI, Rochester MN,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Chicago IL, Rochester MN, Toronto, Spartanburg SC,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase 1, Phase 2, Recruiting
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
for
Ulcerative Colitis (UC)
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18 - 70+
Code: NCT07427017
Phase 2, Recruiting
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
for
Macular Telangiectasia Type 2 (MacTel)
Location: Chicago IL, Grand Rapids MI, Cincinnati OH,
Sponsor: Neurotech Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06971939
Recruiting
Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial
for
Biliary Diseases, Pancreatic Duct Disorder
Location: Chicago IL
Sponsor: Rush University Medical Center
Sex: All
Age: 19+
Code: NCT06895785
Recruiting
Procedural Framing and Epidural Steroid Injection Outcomes
for
Lumbosacral Radiculopathy
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 0+
Code: NCT07498140
Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Chicago IL, Cleveland OH, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06015880
Phase 1, Recruiting
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy